c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Citizens downgrades Foghorn Therapeutics stock rating on drug discontinuation
Investing.com | Oct 1, 2026 3:46 PM EDT
Read original article